Wanjia Group (00401.HK) Hong Kong Hot Stock Analysis

Wanjia Group (00401.HK) is a popular stock included in the Hong Kong Stock Market Surge List of the East Money App on December 3, 2025 [1]. According to data, the stock closed at HK$0.132 on October 28, 2025, with a market capitalization of approximately HK$739 million [2]. The interim results on November 19, 2025, showed that the company’s revenue increased by 2.40% year-on-year due to growth in the hemodialysis business, but it still recorded an overall net loss of HK$71.2 million [2].
Recent (after November) news and price trends have not been fully reflected in existing data channels, and real-time and daily price tools have not returned the latest data. Combining fundamentals and market performance, the stock’s entry into the hot list is more likely due to short-term price fluctuations or speculative trading activities rather than sustained fundamental improvement.

1. The hemodialysis business in the healthcare sector is the core driver of the company’s interim revenue growth, showing business potential in the segmented field [2].
2. Despite revenue growth, the company is still in a loss-making state, reflecting challenges in cost control or business scaling [2].
3. Due to the lack of recent public information support, this hot list ranking is more likely the result of short-term trading momentum or speculative capital promotion [1].

• Risks
  : The company is currently in a loss-making state, and fundamentals have not yet achieved profitability [2]; the lack of recent data casts doubt on the sustainability of market performance; speculative trading may trigger significant stock price fluctuations [1].
• Opportunities
  : The hemodialysis business, as an essential need in the healthcare sector, has long-term growth potential [2]; if the company can effectively optimize its cost structure, there may be room for improvement in future profitability.

Wanjia Group (00401.HK) entered the Hong Kong Stock Surge List of the East Money App on December 3, 2025 [1]. As of October 28, 2025, the stock price was HK$0.132 with a market capitalization of approximately HK$739 million [2]. Interim results showed a 2.40% revenue growth but a net loss of HK$71.2 million; the hot list performance lacks clear recent fundamental support and may be driven by short-term speculative activities.